"Available data from limited studies show administration of recombinant ACE2 improves lung damage caused by respiratory viruses, suggesting ibuprofen use may be beneficial in COVID-19 disease," finds Kutti Sridharan, Gurusaravanan MD and colleagues in a new study.
This review illustrates and provides an overview of the clinical implications of COVID-19 on the liver in healthy and diseased states as well as the implications of common liver disorders on the outcome of COVID-19.
A sudden onset of taste disturbances should raise suspicion of COVID-19. This article analyzes the various studies focusing on taste disturbances as a reliable early symptom for COVID-19 screening.
The authors report the case of a 2-month-old infant with severe acute respiratory syndrome coronavirus 2 infection presenting with fever, tachycardia and elevated interleukin-6, who was diagnosed with myocarditis and treated with immunoglobulins.
This study investigates the prevalence of sleep problems, depression and anxiety symptoms among conscripted frontline nurses fighting COVID-19 in Wuhan.
The SARS-CoV-2 pandemic presents a threat to healthcare systems worldwide. Trauma centers may be uniquely impacted, given the need for rapid invasive interventions in the severely injured and the growing incidence of community infection. We discuss the impact that SARS-CoV-2 has had in our trauma center and our steps to limit the potential exposures.
In patients with acute respiratory distress syndrome from coronavirus disease 2019, potential for lung recruitment presents large variability, while elevated dead space fraction may be a specific pathophysiological trait. These findings may guide selection of personalized mechanical ventilation settings.
